ELOVL2 and neuroblastoma: ELOVL2 (Elongation Of Very Long Chain Fatty Acids Protein 2) is widely considered a biomarker for aging and silencing by DNA methylation [5, 9] and has been occasionally described in the context of oncogenesis, e.g., in breast and renal cell cancer or neuroblastoma [8, 17, 34].